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 Abstract: We present a case of Child-Pugh’s class A cirrhosis with HVC in a 64 years old patient. The 
patient came after the clinical evaluation with level of HCV – RNA test 3.090.000 Ui/ml and many associated 
problems. He followed the medicine recommendations and decided to use the modulators treatment.     
 
INTRODUCTION 
 
 Because of chronic damage to the liver, scar tissue slowly replaces normal functioning 
liver tissue, progressively diminishing blood flow through the liver. As the normal liver tissue 
is lost, nutrients, hormones, drugs and poisons are not processed effectively by the liver. In 
addition, protein production and other substances produced by the liver are inhibited. 
 Cirrhosis is a progressive liver disease, and damage sustained to the liver is irreversible. 
 However, with proper nutrition, avoidance of certain toxins (i.e., alcohol), vitamin 
supplementation, and management of cirrhosis complications, further liver damage can often 
be delayed or stopped. In severe cases of cirrhosis, liver transplantation may be considered. 
 Cirrhosis is the third most common cause of death after heart disorders and cancer 
among people aged 45 to 65. The scar tissue forms bands throughout the liver, destroying the 
liver's internal structure and impairing the liver's ability to regenerate itself or function. The 
liver is less able to do the following: break down waste products made in the body; Produce 
enough bile salts, which help the body absorb fats (in disorders of bile excretion); Remove 
toxins; Process (metabolize) drugs; Produce proteins that help blood clot (clotting factors) and 
albumin for holding fluid in blood vessels. 
 
MATERIALS AND METHODS 
 We analyzed our case, male, 64 years old, with Child-Pugh’s class A cirrhosis with 
HVC using the anamnesis, historic disease, clinical and para-clinical tests and the non-linear 
system OBERON to establish the bio-compatibility of treatment (including the modulators 
treatment) and follow periodically the state health. Dates for examination with the 
bioresonance system were: 4th of March and 26 of June. Dates for specific analyses were: 10th 
of March, 1st of April, 16th of May and 14th of July. 
 
RESULTS AND DISCUSSIONS 
 
 We made a computer functional analysis using the non-linear system Oberon on March, 
4th 2008 and the image was clear: liver with hyperechogenic internal ecostructure homogenic, 
gall-bladder diskinesia associated, with sediments along the main vessels of trunk, a cardiac 
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defect, lipid metabolism turbulences, a bones’ demineralization, diabetes second type 
compensated by diet. The bio-compatibility between patient and modulators was: 
- for liver – 3 DIEE® + 70%; 
- for heart – 2 DIEE® + 48%; 
- for brain – 2 DIEE® + DEA® + 36%; 
- for prostate - 2 DIEE® + 57%; 
- for lungs - 2 DIEE® + DEA® + 50%; 
- for pancreas and spleen - 2 DIEE® + DEA® + 58%; 
- for kidneys and adrenals - 2 DIEE® + DEA® + 30%. 
 The recommended modulators schedule was completely as follow: 1 on the third eye, 1 
to cerebellum, 1 to the breastbone base, 3 on the liver region, 1 cervical, 1 lumbar, 2 for 
pancreas, 2 for prostate, 2 for foot, 2 for adrenals, 2 for lungs and 2 to inguinal zones an 1 for 
energy what he eat and drink, including the drugs.     
 On March 10th 2008 values of the most important analyses are: GGT = 168 U/L, PLT = 
142*103/µL, INR = 2,44, ALT = 73 U/L, AST = 55 U/L, Total Bilirubin = 1,5 mg/dL, HCV – 
RNA = 3.090.000 UI/ml.    
 In April 1st 2008 the diagnostic was: Child-Pugh’s class A cirrhosis with hepatitis C, 
ischemic cardiac disease, metal valve prosthesis, chronicle cardiac insufficiency second class 
NYHA, erosive gastritis, adulterate tolerance to glucose.  
 Values of the most important analyses are: GGT = 181 U/L, INR = 2,62, ALT = 80 U/L, 
AST = 48 U/L, Total Bilirubin = 0,81 mg/dL. It wasn’t recommended the Interferon 
treatment, but Nexium, Propanolol, Prestarium, Digoxin, Syntrom, Ursofial K.      
 So, after 4 weeks from the beginning of treatment INR is still over normal, ALT more 
with 7 units as on March, AST decreased with 7 units and total bilirubin is normal. It wasn’t 
done the HCV-RNA test.      
 After 1 months and a half, the HCV-RNA test result was 1.240.000 UI/ml, which means 
a reduction to a half. The others analyses are: GGT = 220 U/L, PLT = 148*103/µL, INR = 
1,96, ALT = 71 U/L, Total Bilirubin = 1,2 mg/dL So from April ALT decreased with 9 units 
and total bilirubin increases with 0,21 units. 
 After 4 months from the beginning of treatment using modulators we remade the 
computer functional analyze information was clear: liver with inflammatory structure, 
cirrhosis didn’t represent a risk (coefficient of disease is 2, 10, over 1, 5), remained sensibility 
to hepatic artery, with ecostructure generally homogenic on the third level and only 2 points 
of 4th level situated on each lob; with sediment to artery’s trunk, diabetes, prostate adenoma 
risk, atherosclerosis installed to main vessels of trunk, anemia, with sensibility to lumbar - 
sacral and thoracic sections of spinal column (T9-T10, L1 – L6), an immunity decrease. 
 After two weeks from this evaluation the analyses had the next values: GGT = 200 U/L, 
PLT = 142*103/µL, INR = 2,56, ALT = 62 U/L, AST = 51 U/L, Total Bilirubin = 1,07 mg/dL, 
HCV – RNA = 856.388 UI/ml. So the viremia was favorable modified and ALT was 
normalized. Remain only INR, GGT and AST to establish in the normal interval and the 
HCV-RNA to be negative. Anyway, the evolution of HCV-RNA is spectacular, even patient 
has a diet and a natural treatment, besides the modulators. 
 
CONCLUSIONS 
 
 HCV-RNA test identified whether the virus is in the blood, indicated that patient has an 
active infection with HCV. It is the most important value that suffers a great involution, from 
3.090.000 UI/ml to 856.388 UI/ml.  
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 On the other side, the normalization of ALT according with the increase of HCV-RNA 
demonstrates a benefic effect for the hepatic function.  
 All parameters suffered variations, lower or higher than dates from March, but 
modulators started to negativate the viremia and, after stabilization of normal, all others 
values have to integrate in normal intervals. Modulators work starting with the most difficult 
problem – in our case is viremia – and finish with the insignificant one. Till the results of 
HCV-RNA will become negative, all parameters will have variations.  
 The hepatic structure suffered modifications, keeping the general homogeneity, but 
delimitating the affected regions (points from hepatic lobs) and trying to reabsorb its.   
 All values of hepatic dates have direct influence to the blood circulation. The 
sediments along the main vessels of the trunk are recycled and eliminated by natural’s ways. 
That’s why modulators must be kept about 2 years, even in cirrhosis. 
 We wished to demonstrate that these modulators can change the serum parameters and 
the general health state to improve all functions of the body.    
 
